Advertisement
Advertisement
AUPH
Aurinia Pharmaceuticals Inc
14.85
USDSponsored
-0.02
-0.13%
Jan 16, 15:59 UTC -5
Closed
After-Market
14.46
-0.40
-2.66%
AUPH Earnings Reports
Positive Surprise Ratio
AUPH beat 25 of 40 last estimates.
63%
Next Report
Date of Next Report
Feb 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
$76.34M
/$0.22
Implied change from Q3 25 (Revenue/ EPS)
+3.91%
/-4.35%
Implied change from Q4 24 (Revenue/ EPS)
+27.52%
/+2100.00%
Aurinia Pharmaceuticals Inc earnings per share and revenue
On Nov 04, 2025, AUPH reported earnings of 0.23 USD per share (EPS) for Q3 25, beating the estimate of 0.16 USD, resulting in a 40.93% surprise. Revenue reached 73.47 million, compared to an expected 68.77 million, with a 6.84% difference. The market reacted with a +8.35% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.22 USD, with revenue projected to reach 76.34 million USD, implying an decrease of -4.35% EPS, and increase of 3.91% in Revenue from the last quarter.
FAQ
What were Aurinia Pharmaceuticals Inc's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Aurinia Pharmaceuticals Inc reported EPS of $0.23, beating estimates by 40.93%, and revenue of $73.47M, 6.84% above expectations.
How did the market react to Aurinia Pharmaceuticals Inc's Q3 2025 earnings?
The stock price moved up 8.35%, changed from $13.17 before the earnings release to $14.27 the day after.
When is Aurinia Pharmaceuticals Inc expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Aurinia Pharmaceuticals Inc's next earnings report?
Based on 8
analysts, Aurinia Pharmaceuticals Inc is expected to report EPS of $0.22 and revenue of $76.34M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement